speakers | directors

course director



kevin staley, md

Chief of Pediatric Neurology,
Massachusetts General Hospital

Joseph P. and Rose F. Kennedy Professor of Child Neurology and Mental Retardation,
Harvard Medical School

Kevin Staley trained in physics at Loyola Marymount University; in medicine and pediatric neurology at the University of California, San Diego; and in cellular electrophysiology at Stanford University School of Medicine. He is the Joseph P. and Rose F. Kennedy Professor of Child Neurology and Mental Retardation at Harvard Medical School, and the chief of the Pediatric Neurology Service at Massachusetts General Hospital. His research forms the scientific foundation for the Boston clinical trial of diuretics to manipulate neuronal chloride transport as a candidate adjunctive treatment for neonatal seizures (clinicaltrials.gov #NCT00830531).

co-directors



david dredge, md

Director of Resident Education for Child Neurology,
Massachusetts General Hospital

Assistant Professor in Neurology,
Harvard Medical School

Dr. Dredge joined the Massachusetts General Hospital Department of Pediatric Neurology in September 2016 as an Assistant Professor in Neurology Director of Resident Education for Child Neurology. Dr. Dredge was previously on staff at Baystate Medical Center and Tufts University, where he served as an Assistant Professor in Pediatrics and Director of Student and Resident Education for the pediatric neurology department from 2009 to 2016.

Dr. Dredge completed residency training in Pediatrics at Baystate Medical Center and residency training in Neurology at Massachusetts General Hospital. He attended the University of Massachusetts Medical School and Carleton College as an undergraduate.

Dr. Dredge is a general pediatric neurologist and sees patients of all kinds. His clinical areas of interest include fetal/neonatal neurology and epilepsy. Areas of academic interest include neonatal seizures and sleep activated childhood epilepsy syndromes.

In his personal time, he spends time with his wife and 4 children, plays the guitar and practices tai chi and kung-fu.

florian eichler, md

Director, Leukodystrophy Service,
Massachusetts General Hospital

Associate Professor,
Harvard Medical School

Dr. Eichler is an Associate Professor of Neurology at Massachusetts General Hospital (MGH) and Harvard Medical School. He is trained in Neurology and Neurogenetics with a focus in neurodegenerative disorders. He was a Neurogenetics Research Fellow at Johns Hopkins and is currently Director of the Leukodystrophy Service at MGH. He recently became Director of the Center for Rare Neurological Diseases at MGH. Dr. Eichler runs a laboratory at MGH that explores the relationship of mutant genes to specific biochemical defects and their contribution to neurodegeneration. His laboratory has extensive experience in various molecular techniques, as he is frequently assessing gain and loss of function questions in genetic disease models. He identified two neurotoxic desoxysphingoid bases that accumulate in mutant transgenic mice and humans with HSAN1. For this work he received the Wolfe Neuropathy Research Prize from the American Neurological Association in 2009. Dr. Eichler is the principal investigator of several NIH-funded studies on neurogenetic disorders as well as gene therapy trial of adrenoleukodystrophy (ALD). He also serves as chair of the consortium ALD Connect, a patient powered research network that was recently awarded a contract from PCORI.